Effects of Lycium barbarum L. root bark extract on alloxan-induced diabetic mice

Therapy

Volumn 4, Issue 5, 2007, Pages 547-553

  Gao, Dawei ^a   Li, Qingwang ^a,b   Liu, Zhiwei ^a   Li, Ying ^a   Liu, Zhihua ^b   Fan, Yusheng ^b   Han, Zengsheng ^a   Li, Jian ^a  

^a YANSHAN UNIVERSITY   (China)

^b NORTHWEST A F UNIVERSITY   (China)

Author keywords

Diabetes; Hypoglycemia; Hypolipidemia; Insulin; Lycium barbarum L.

Indexed keywords

ALLOXAN; CHOLESTEROL; GLUCOSE; INSULIN; LYCIUM BARBARUM EXTRACT; LYCIUM EXTRACT; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ALLOXAN DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BARK; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE CONTROL; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG MEGADOSE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HYPOGLYCEMIA; HYPOLIPEMIA; INSULIN BLOOD LEVEL; INSULIN RELEASE; LD 50; LOW DRUG DOSE; LYCIUM; LYCIUM BARBARUM; MALE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PLANT ROOT; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN;

EID: 35348829254     PISSN: 14750708     EISSN: 1744831X     Source Type: Journal    
DOI: 10.2217/14750708.4.5.547     Document Type: Article

References (37)

1. Wild S, Roqlic G, Green A et al.: Global prevalence of diabetes estimates for the year 2000 and projections for 2030 Diabetes Care 27(5), 1047-1053 (2004).
2. Nammi S, Boini MK, Lodagala SD et al.: The juice of fresh leaves of Cathranthus roseus Linn. Reduces blood glucose in normal and alloxan diabetic rats. BMC Complement. Altern. Med. 3, 1-4 (2003).
3. Ozsoy-Sacan O, Karabulut-Bulan O, Bolkent S et al.: Effects of Chard (Beta vulgarir L. var cicla) on the liver of the diabetic rats: a morphological and biochemical study. Biosci. Biotech. Biochem. 68, 1640-1648 (2004).
4. Huang XH, Zhou XW, Wang Q et al.: Effect of relieving-fever and reducing plasmas glucose of 3 kinds of Digupi on albino rats. J. Fujian Agric. Uni. 29(2), 229-232 (2000).
5. Zheng HZ: Chinese herb modern research and Application (Second Volume). Xueyuan Publisher, Beijing, China, 1789-1795 (1998).
6. Cao Y: Treatment diabetic-feet using multiherbs from ancestors. Chinese J. Ethnomed. Ethnopharm. 62, 148 (2003).
7. Luo Q, Li JW, Zhang SH: Effect of Lyclum barbarum L. polysaccharides-X on reducing blood glucose in diabetic rabbits. Chinese J. Trophology 19, 173-177 (1997).
8. Yang XF, Li SG, Yu DZ et al.: Effects of Cortex lych granules on serum glucose, lipid and immunologic function. Med. J. Qilu 15(2), 84-86 (2000).
9. Wang SM: Chinese drugs Identified atlas. Chinese Xueyuan Publishing Company, China (2005).
10. Sezik E, Aslan M, Yesilada E et al.: Hypoglycaemic activity of Gentiana olivieri and isolation of the active constituent through bioassay-directed fractionation techniques. Life Sci. 76(11), 1223-1238 (2005).
11. Lu YH, Wei DZ, Jiang XM: Extraction and Isolation of Active Compounds from Chinese Herb. Chemistry Industry Publishing Company, China (2005).
12. Trinder P: Determination of blood glucose using an oxidase peroxidase system with a non-carcinogenic chromogen. J. Clin. Pathol. 22, 158-161 (1969).
13. Lorke DA: New approach to practical acute toxicity testing. Arch. Toxicol. 54, 275-287 (1983).
14. Dey L, Zhang L, Yuan CS: Anti-diabetic and anti-obese effects of ginseng berry extract: comparison between intraperitoneal and oral administrations. Am. J. Chin. Med. 30(4), 645-647 (2002).
15. Singab ANB, El-Beshbishy HA, Yonekawa M et al.: Hypoglycemic effect of Egyptian Morus alba root bark extract: Effect on diabetes and lipid peroxidation of streptozotocin-induced diabetic rats. J. Ethnopharmacol. 100, 333-338 (2005).
16. Kar A, Houdhary BK, Andyopadhyay NG: Comparative evaluation of hypoglycaemic activity if some Indian medicinal plants in alloxan diabetic rats. J. Ethnopharmacol. 84, 105-108 (2003).
17. Jayakar B, Rajkapoor B, Suresh B: Effect of Caralluma attenuate in normal and alloxan induced diabetic rats. J. Herbal Pharmacother. 4, 35-40 (2004).
18. Junod A, Lambert AE, Stauffacher W et al.: Diabetogenic action of streptozotocin: relationship of dose to metabolic response. J. Clin. Invest. 48, 2129-2139 (1969).
19. Craft NE, Failia ML: Zinc, iron. and copper absorption in the streptozotocin-diabetic rat. Am. J. Physiol. Endocrinol. Metab. 244, E122-E128 (1983).
20. Failla ML, Kiser RA: Altered tissue content and cytosol distribution of trace metals in experimental diabetes. J. Nutr. 111, 1900-1909 (1981).
21. Ravi K, Ramachandran B, Subramanian S: Protective effect of Eugenia jambolana seed kernel on tissue antioxidants in streptozotocin-induced diabetic rats. Biol. Pharma. Bull. 27, 1212-1217 (2004).
22. Bierman EL, Amaral JAP, Balknap, BH: Hyperlipidemia and diabetes mellitus. Diabetes 25, 509-515 (1975).
23. Xie W, Xing D, Sun H et al.: The effects of Ananas comosus L. leaves on diabetic-dyslipidemic rats induced by alloxan and a high-fat/high-cholesterol diet. Am. J. Chin. Med. 33(1), 95-105 (2005).
24. Ryle PR, Barker J, Gaines PA et al.: Alloxan-induced diabetes in the rat - protective action of (-) epicatechin? Life Sci. 34(6), 591-595 (1984).
25. + channels and diabetes mellitus. Physiology 5, 143-147 (1990).
26. +-currents in isolated mouse pancreatic β-cells. FEBS Lett. 261(1), 187-190 (1990).
27. Sarafidis PA, Bakris GL: The antinatriuretic effect of insulin: an unappreciated mechanism for hypertension associated with insulin resistance? Am. J. Nephrol. 27, 44-54 (2007).
28. Bopanna KN, Kannan J, Sushma G et al.: Antidiabetic and antihyperlipidemic effect of neem seed, kernel powder on alloxan diabetic rabbits. Ind. J. Pharmacol. 29, 162-167 (1997).
29. Hayashi T, Hirano T, Yamamoto T et al.: Intensive insulin therapy reduces small dense low-density lipoprotein particles in patients with Type 2 diabetes mellitus. relationship to triglyceride-rich lipoprotein subspecies. Metabolism 55(7), 879-884 (2006).
30. Mazzone T, Foster D, Chait A: In vivo stimulation of low-density lipoprotein degradation by insulin. Diabetes 33, 333-338 (1984).
31. Quiñones-Galvan A, Sironi AM, Baldi S et al.: Evidence that acute insulin administration enhances LDL cholesterol susceptibility to oxidation in healthy humans. Arterioscler. Thromb. Vasc. Biol. 19, 2928-2932 (1999).
32. Frayn KN: Insulin resistance and lipid metabolism. Curr. Opin. Lipidol. 4, 197-204 (1993).
33. Godon T, Fisher M, Ernst W et al.: The relation of diet to LDL, VLDL, total cholesterol and triglycerides in white adults. The lipid research clinic programme prevalence study. Arteriosclerosis 2, 502-512 (1982).
34. Kannel WB, Castelli WP, Gordon T et al.: Serum cholesterol, lipoproteins and the risk of coronary heart disease - the Framingham Study. Ann. Intern. Med. 74, 1-12 (1971).
35. Bouziotas C, Koutedakis Y, Nevill A et al.: Greek adolescents, fitness, fatness, fat intake, activity, and coronary heart disease risk. Arch. Dis. Child. 89, 41-44 (2004).
36. Hoogeveen RC, Gambhir JK, Gambhir DS et al.: Evaluation of Lp[a] and other independent risk factors for CHD in Asian Indians and their USA counterparts. J. Lipid Res. 42, 631-638 (2001).
37. Kalk WJ, Joffe BI: Differences in coronary heart disease prevalence and risk factors in African and White patients with Type 2 diabetes. Diabetes Res. Clin. Prac. 77, 107-112 (2007).